OpenAlex
PricingAboutJobs
Log inGet started
Work

The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease

HTML

Year: 2010
Type: review
Source: Pulmonary Pharmacology & Therapeutics
DOI: 10.1016/j.pupt.2010.03.011
Authors: Armin Hatzelmann, Esteban J. Morcillo, Giuseppe Lungarella, Serge Adnot, Shahin Sanjar, Rolf Beume, Christian Schudt, Hermann Tenor
Institutions: Universitat de València, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Centro de Investigación Biomédica en Red, University of Siena, Inserm, Centre Hospitalier Universitaire Henri-Mondor, Hôpitaux Universitaires Henri-Mondor
Language: English

Topic: Phosphodiesterase function and regulation
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: roflumilast, phosphodiesterase-4 inhibitors, chronic obstructive pulmonary disease, cAMP signaling, mucociliary dysfunction, pulmonary fibrosis, emphysema, pulmonary hypertension, pulmonary vascular remodeling, oxidative stress, neutrophils, macrophages, T cells, endothelial cells, epithelial cells, smooth muscle cells, fibroblasts, drug development
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1971574036
FWCI: 2.485
Cites: 273
Cited by: 336
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms